Tag:Food and Drug Administration (FDA)

Proposed Legislation Reflects a Misunderstanding of Drug Safety Programs: Professor Lietzan in The Hill

November 21st, 2016

The Hill published an op-ed written by Professor Erika Lietzan on the proposed “CREATES Act.” In the article, Professor Lietzan explains that the proposed legislation reflects a misunderstanding of the…

Mizzou Law Faculty Member Receives Thomas Edison Innovation Fellowship

November 16th, 2016

Professor Erika Lietzan has been awarded a second Thomas Edison Innovation Fellowship from the Center for the Protection of Intellectual Property at George Mason University’s Antonin Scalia Law School. The…

FDA’s Approval of Drug Fell Within Legal Authority: Professor Lietzan

October 7th, 2016

Professor Erika Lietzan was recently quoted by STAT regarding the Food & Drug Administration’s recent decision to grant accelerated approval to the first drug for Duchenne muscular dystrophy. The decision…

Professor Lietzan Cowrites Chapter in FDA in the 21st Century

September 10th, 2015

Professor Erika Lietzan recently cowrote an essay in a book published by Columbia University Press, FDA in the 21st Century, with Professor Henry Grabowski of Duke University. The book chapter,…

Professor Lietzan Publishes on Regulation of Biosimilars and Biotechnology Drugs, Devices

May 27th, 2015

Professor Erika Lietzan is the editor of a recently-published book on premarket and postmarket regulation of biotechnology drugs and devices. The book, Medical Biotechnology: Premarket and Postmarket Regulation, contains a…